3 results
Approved WMOCompleted
To assess the analgesic efficacy, safety, and tolerability of once daily orally administered GRT6005 in a total of 3 fixed doses (i.e., 200 µg, 400 µg, and 600 µg GRT6005) compared to placebo in subjects with moderate to severe chronic LBP.
Approved WMOCompleted
Primary Safety Objective: To describe the safety profile of 20vPnC
Approved WMOPending
The main objective of this study is to further validate our fUS-technique by comparing and contrasting the spatial and temporal patterns of fUS-defined functional areas with results acquired using fMRI in the same human subject.